Ingredion (INGR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Q1 2026 net sales declined 1% year-over-year to $1.79 billion, with adjusted operating income down 22% to $212 million and reported operating income down 26% to $203 million, mainly due to operational challenges at the Argo facility and softer volumes in Food & Industrial Ingredients U.S./Canada and LATAM.
Net income attributable to shareholders fell 28% year-over-year to $142 million, with gross profit down 14% to $401 million.
Texture & Healthful Solutions delivered its eighth consecutive quarter of volume growth, up 2%, driven by clean label and wellness trends in EMEA and Asia Pacific.
Announced plans to cease operations at the Cabo facility in Brazil by end of Q2 2026 to drive productivity and optimize the network.
Financial highlights
Q1 net sales were $1.79 billion, down 1% year-over-year; gross profit margin declined to 22.4%; adjusted diluted EPS was $2.34, down from $2.97.
Cash from operations was $33 million, reflecting a $205 million working capital investment; capital expenditures totaled $110 million; $52 million in dividends and $14 million in share repurchases.
Reported EPS was $2.22, down from $3.00 in Q1 2025.
Outlook and guidance
Full-year 2026 net sales expected to be flat to up low single digits; adjusted operating income flat to down low single digits; adjusted EPS guidance revised to $10.45–$11.15; reported EPS guidance $9.60–$10.30.
Cash from operations expected at $725–$825 million; capex at $400–$440 million.
Segment guidance: Texture & Healthful Solutions operating income up low single digits; F&II LATAM net sales flat to down low single digits, operating income down low single digits; F&II U.S./Canada net sales down low single digits, operating income down low double digits.
Full-year effective tax rate expected at 26%–27.5%.
Latest events from Ingredion
- Q2 adjusted EPS up 24% and full-year outlook raised, despite lower net sales.INGR
Q2 20249 Jul 2026 - Targets 2%-4% net sales and 7%-9% adjusted EPS CAGR with innovation and disciplined growth.INGR
Investor Day 20258 Jul 2026 - Record Q3 profit and margin gains drive raised outlook and strong cash flow.INGR
Q3 20248 Jul 2026 - Operating and net income rose with margin gains, offsetting sales declines; outlook raised.INGR
Q2 20258 Jul 2026 - Record profit growth and margin expansion in 2024 set the stage for further gains in 2025.INGR
Q4 20248 Jul 2026 - $5B (£3.7B) acquisition forms a global ingredient leader, targeting $130M in synergies by 2030.INGR
M&A announcement8 Jun 2026 - All agenda items passed, with management emphasizing resilience and growth amid global challenges.INGR
AGM 202620 May 2026 - Record adjusted EPS and segment growth in 2025, with a stable 2026 outlook.INGR
Q4 202520 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and major ESG progress.INGR
Proxy filing8 Apr 2026